In a longitudinal study, MS patients with the highest levels of BAFF appeared to be the least likely to experience an exacerbation (43) suggesting that increased BAFF levels in MS may not necessarily contribute to disease. The gene discussed is TNFSF13B; the disease is myeloid sarcoma.